The following articles (labelled with PubMed ID or TBD) are for your review
| PMID | Data | Article Title | Organization |
|---|
| 26735842 |
27 |
Exploring Selective Inhibition of the First Bromodomain of the Human Bromodomain and Extra-terminal Domain (BET) Proteins. |
Centre National de la Recherche Scientifique/INSERM/ULP |
| 26230603 |
176 |
Structure-Based Optimization of Naphthyridones into Potent ATAD2 Bromodomain Inhibitors. |
Glaxosmithkline |
| 26155854 |
125 |
Fragment-Based Discovery of Low-Micromolar ATAD2 Bromodomain Inhibitors. |
Glaxosmithkline |
| 26080064 |
141 |
Structure-Based Design of¿-Carboline Analogues as Potent and Specific BET Bromodomain Inhibitors. |
University of Michigan |
| 25971770 |
10 |
Progress in discovery of small-molecule modulators of protein-protein interactions via fragment screening. |
Pfizer |
| 25314628 |
12 |
Fragment-based screening of the bromodomain of ATAD2. |
Vanderbilt University School of Medicine |
| 25249180 |
146 |
The discovery of I-BET726 (GSK1324726A), a potent tetrahydroquinoline ApoA1 up-regulator and selective BET bromodomain inhibitor. |
Glaxosmithkline |
| 21568322 |
16 |
Discovery and characterization of small molecule inhibitors of the BET family bromodomains. |
Glaxosmithkline |
Search and Browse
